Psychedelic Experiences and Mindfulness are Associated with Improved Wellbeing

References

• Aday, J. S., C. M. Mitzkovitz, E. K. Bloesch, C. C. Davoli, and A. K. Davis. 2020. Long-term effects of psychedelic drugs: A systematic review. Neuroscience and Biobehavioral Reviews 113:179–89. doi:10.1016/j.neubiorev.2020.03.017.
   PubMed Web of Science ®Google Scholar
• Anderson, T., R. Petranker, D. Rosenbaum, C. R. Weissman, L.-A. Dinh-Williams, K. Hui, E. Hapke, and N. A. S. Farb. 2019. Microdosing psychedelics: Personality, mental health, and creativity differences in microdosers. Psychopharmacology 236 (2):731–40. doi:10.1007/s00213-018-5106-2.
   PubMed Web of Science ®Google Scholar
• Baer, R. A., E. L. B. Lykins, and J. R. Peters. 2012. Mindfulness and self-compassion as predictors of psychological wellbeing in long-term meditators and matched nonmeditators. The Journal of Positive Psychology 7 (3):230–38. doi:10.1080/17439760.2012.674548.
   Web of Science ®Google Scholar
• Baer, R. A., G. T. Smith, J. Hopkins, J. Krietemeyer, and L. Toney. 2006. Using self-report assessment methods to explore facets of mindfulness. Assessment 13 (1):27–45. doi:10.1177/1073191105283504.
   PubMed Web of Science ®Google Scholar
• Barrett, F. S., and R. R. Griffiths. 2018. Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates. Current Topics in Behavioral Neurosciences 36:393–430. doi:10.1007/7854_2017_474.
   PubMedGoogle Scholar
• Barrett, F. S., M. W. Johnson, and R. R. Griffiths. 2015. Validation of the revised mystical experience questionnaire in experimental sessions with psilocybin. Journal of Psychopharmacology 29 (11):1182–90. doi:10.1177/0269881115609019.
   PubMed Web of Science ®Google Scholar
• Barrett, F. S., M. W. Johnson, and R. R. Griffiths. 2017. Psilocybin in long-term meditators: Effects on default mode network functional connectivity and retrospective ratings of qualitative experience. Drug and Alcohol Dependence 171 (2):e15–e16. doi:10.1007/s00213-018-5106-2.
   Web of Science ®Google Scholar
• Bester, E., P. Naidoo, and A. Botha. 2016. The role of mindfulness in the relationship between life satisfaction and spiritual wellbeing amongst the elderly. Social Work 52(2. doi:10.15270/52-2-503.
   Google Scholar
• Birtwell, K., K. Williams, H. van Marwijk, C. J. Armitage, and D. Sheffield. 2019. An exploration of formal and informal mindfulness practice and associations with wellbeing. Mindfulness 10 (1):89–99. doi:10.1007/s12671-018-0951-y.
   PubMed Web of Science ®Google Scholar
• Bøhling, F. 2017. Psychedelic pleasures: An affective understanding of the joys of tripping. The International Journal on Drug Policy 49:133–43. doi:10.1016/j.drugpo.2017.07.017.
   PubMed Web of Science ®Google Scholar
• Brown, K. W., and R. M. Ryan. 2003. The benefits of being present: Mindfulness and its role in psychological well-being. Journal of Personality and Social Psychology 84 (4):822–48. doi:10.1037/0022-3514.84.4.822.
   PubMed Web of Science ®Google Scholar
• Campos, D., A. Cebolla, S. Quero, J. Bretón-López, C. Botella, J. Soler, J. García-Campayo, M. Demarzo, and R. M. Baños. 2016. Meditation and happiness: Mindfulness and self-compassion may mediate the meditation–happiness relationship. Personality and Individual Differences 93:80–85. doi:10.1016/j.paid.2015.08.040.
   Web of Science ®Google Scholar
• Carhart-Harris, R. L., R. Leech, P. J. Hellyer, M. Shanahan, A. Feilding, E. Tagliazucchi, D. R. Chialvo, and D. Nutt. 2014. The entropic brain: A theory of conscious states informed by neuroimaging research with psychedelic drugs. Frontiers in Human Neuroscience 8:20. doi:10.3389/fnhum.2014.00020.
   PubMed Web of Science ®Google Scholar
• Davidson, J. M. 1976. The physiology of meditation and mystical states of consciousness. Perspectives in Biology and Medicine 19 (3):345–80. doi:10.1353/pbm.1976.0042.
   PubMed Web of Science ®Google Scholar
• Davis, A. K., J. M. Clifton, E. G. Weaver, E. S. Hurwitz, M. W. Johnson, and R. R. Griffiths. 2020. Survey of entity encounter experiences occasioned by inhaled N,N-dimethyltryptamine: Phenomenology, interpretation, and enduring effects. Journal of Psychopharmacology 34 (9):1008–20. doi:10.1177/0269881120916143.
   PubMed Web of Science ®Google Scholar
• de Castro, J. M. 2015. Meditation has stronger relationships with mindfulness, kundalini, and mystical experiences than yoga or prayer. Consciousness and Cognition 35:115–27. doi:10.1016/j.concog.2015.04.022.
   PubMed Web of Science ®Google Scholar
• Diener, E. D., R. A. Emmons, R. J. Larsen, and S. Griffin. 1985. The satisfaction with life scale. Journal of Personality Assessment 49 (1):71–75. doi:10.1207/s15327752jpa4901_13.
   PubMed Web of Science ®Google Scholar
• Doblin, R. E., M. Christiansen, L. Jerome, and B. Burge. 2019. The past and future of psychedelic science: an introduction to this issue. Journal of Psychoactive Drugs 51 (2):93–97. doi:10.1080/02791072.2019.1606472.
   PubMed Web of Science ®Google Scholar
• Erowid Psychoactive Vaults. (2018, March 12). Erowid. https://www.erowid.org/psychoactives/psychoactives.shtml
   Google Scholar
• Forstmann, M., D. A. Yudkin, A. M. B. Prosser, S. M. Heller, and M. J. Crockett. 2020. Transformative experience and social connectedness mediate the mood-enhancing effects of psychedelic use in naturalistic settings. Proceedings of the National Academy of Sciences of the United States of America 117 (5):2338–46. doi:10.1073/pnas.1918477117.
   PubMed Web of Science ®Google Scholar
• Garland, E. L., N. A. Farb, P. R. Goldin, and B. L. Fredrickson. 2015. The Mindfulness-to-Meaning Theory: Extensions, Applications, and Challenges at the Attention–Appraisal–Emotion Interface. Psychological Inquiry 26 (4):377–87. doi:10.1080/1047840X.2015.1092493.
   Web of Science ®Google Scholar
• Garland, E., S. Gaylord, and J. Park. 2009. The role of mindfulness in positive reappraisal. Explore 5 (1):37–44. doi:10.1016/j.explore.2008.10.001.
   Google Scholar
• Garland, E. L., A. W. Hanley, P. R. Goldin, and J. J. Gross. 2017. Testing the mindfulness-to-meaning theory: Evidence for mindful positive emotion regulation from a reanalysis of longitudinal data. PloS One 12 (12):e0187727. doi:10.1016/j.drugpo.2017.07.017.
   PubMed Web of Science ®Google Scholar
• Glück, J., S. König, K. Naschenweng, U. Redzanowski, L. Dorner, I. Straßer, and W. Wiedermann. 2013. How to measure wisdom: Content, reliability, and validity of five measures. Frontiers in Psychology 4:405. doi:10.3389/fpsyg.2013.00405.
   PubMed Web of Science ®Google Scholar
• Goldberg, S. B., R. P. Tucker, P. A. Greene, R. J. Davidson, B. E. Wampold, D. J. Kearney, and T. L. Simpson. 2018. Mindfulness-based interventions for psychiatric disorders: A systematic review and meta-analysis. Clinical Psychology Review 59:52–60. doi:10.1016/j.cpr.2017.10.011.
   PubMed Web of Science ®Google Scholar
• Goyal, M., S. Singh, E. M. S. Sibinga, N. F. Gould, A. Rowland-Seymour, R. Sharma, Z. Berger, D. Sleicher, D. D. Maron, H. M. Shihab, et al. 2014. Meditation programs for psychological stress and well-being: A systematic review and meta-analysis. JAMA Internal Medicine 174 (3):357–68. doi:10.1001/jamainternmed.2013.13018.
   PubMed Web of Science ®Google Scholar
• Griffiths, R. R., M. W. Johnson, W. A. Richards, B. D. Richards, R. Jesse, K. A. MacLean, F. S. Barrett, M. P. Cosimano, and M. A. Klinedinst. 2018. Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors. Journal of Psychopharmacology 32 (1):49–69. doi:10.1177/0269881117731279.
   PubMed Web of Science ®Google Scholar
• Griffiths, R. R., M. W. Johnson, W. A. Richards, B. D. Richards, U. McCann, and R. Jesse. 2011. Psilocybin occasioned mystical-type experiences: Immediate and persisting dose-related effects. Psychopharmacology 218 (4):649–65. doi:10.1007/s00213-011-2358-5.
   PubMed Web of Science ®Google Scholar
• Griffiths, R., W. Richards, M. Johnson, U. McCann, and R. Jesse. 2008. Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later. Journal of Psychopharmacology 22 (6):621–32. doi:10.1177/0269881108094300.
   PubMed Web of Science ®Google Scholar
• Griffiths, R. R., W. A. Richards, U. McCann, and R. Jesse. 2006. Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology 187(3):268–83. discussion 284–292. doi:10.1007/s00213-006-0457-5.
   PubMed Web of Science ®Google Scholar
• Gu, J., C. Strauss, R. Bond, and K. Cavanagh. 2015. How do mindfulness-based cognitive therapy and mindfulness-based stress reduction improve mental health and wellbeing? A systematic review and meta-analysis of mediation studies. Clinical Psychology Review 37:1–12. doi:10.1016/j.cpr.2015.01.006.
   PubMed Web of Science ®Google Scholar
• Gunaratana, H. 1993. Sati: Mindfulness in Plain English. Boston, MA: California Buddhist Vihara Society.
   Google Scholar
• Haijen, E. C. H. M., M. Kaelen, L. Roseman, C. Timmermann, H. Kettner, S. Russ, D. Nutt, R. E. Daws, A. D. G. Hampshire, R. Lorenz, et al. 2018. Predicting responses to psychedelics: a prospective study. Frontiers in Pharmacology 9:897. doi:10.3389/fphar.2018.00897.
   PubMed Web of Science ®Google Scholar
• Hartogsohn, I. 2018. The meaning-enhancing properties of psychedelics and their mediator role in psychedelic therapy, spirituality, and creativity. Frontiers in Neuroscience 12:129. doi:10.3389/fnins.2018.00129.
   PubMed Web of Science ®Google Scholar
• Henry, J. D., and J. R. Crawford. 2005. The short-form version of the depression anxiety stress scales (DASS-21): Construct validity and normative data in a large non-clinical sample. The British Journal of Clinical Psychology/the British Psychological Society 44 (2):227–39. doi:10.1348/014466505X29657.
   PubMed Web of Science ®Google Scholar
• Holze, F., P. Vizeli, F. Müller, L. Ley, R. Duerig, N. Varghese, A. Eckert, S. Borgwardt, and M. E. Liechti. 2020. Distinct acute effects of LSD, MDMA, and D-amphetamine in healthy subjects. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 45 (3):462–71. doi:10.1038/s41386-019-0569-3.
   PubMed Web of Science ®Google Scholar
• Johnson, M. W., P. S. Hendricks, F. S. Barrett, and R. R. Griffiths. 2019. Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function. Pharmacology & Therapeutics 197:83–102. doi:10.1016/j.pharmthera.2018.11.010.
   PubMed Web of Science ®Google Scholar
• Johnson, M., W. Richards, and R. Griffiths. 2008. Human hallucinogen research: Guidelines for safety. Journal of Psychopharmacology 22 (6):603–20. doi:10.1177/0269881108093587.
   PubMed Web of Science ®Google Scholar
• Josipovic, Z. 2014. Neural correlates of nondual awareness in meditation. Annals of the New York Academy of Sciences 1307 (1):9–18. doi:10.1111/nyas.12261.
   PubMed Web of Science ®Google Scholar
• Jungaberle, H., S. Thal, A. Zeuch, A. Rougemont-Bücking, M. von Heyden, H. Aicher, and M. Scheidegger. 2018. Positive psychology in the investigation of psychedelics and entactogens: A critical review. Neuropharmacology 142:179–99. doi:10.1016/j.neuropharm.2018.06.034.
   PubMed Web of Science ®Google Scholar
• Kabat-Zinn, J. 1982. An outpatient program in behavioral medicine for chronic pain patients based on the practice of mindfulness meditation: Theoretical considerations and preliminary results. General Hospital Psychiatry 4 (1):33–47. doi:10.1016/0163-8343(82)90026-3.
   PubMed Web of Science ®Google Scholar
• Kabat-Zinn, J., and T. N. Hanh. 2009. Full catastrophe living: using the wisdom of your body and mind to face stress, pain, and illness. New York: Random House Publishing Group. Accessed January 2019. https://play.google.com/store/books/details?id=TVsrK0sjGiUC
   Google Scholar
• Liechti, M. E., P. C. Dolder, and Y. Schmid. 2017. Alterations of consciousness and mystical-type experiences after acute LSD in humans. Psychopharmacology 234 (9–10):1499–510. doi:10.1007/s00213-016-4453-0.
   PubMed Web of Science ®Google Scholar
• Lyvers, M., and M. Meester. 2012. Illicit use of LSD or psilocybin, but not MDMA or nonpsychedelic drugs, is associated with mystical experiences in a dose-dependent manner. Journal of Psychoactive Drugs 44 (5):410–17. doi:10.1080/02791072.2012.736842.
   PubMed Web of Science ®Google Scholar
• MacLean, K. A., M. W. Johnson, and R. R. Griffiths. 2011. Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness. Journal of Psychopharmacology 25 (11):1453–61. doi:10.1177/0269881111420188.
   PubMed Web of Science ®Google Scholar
• Mason, N. L., P. C. Dolder, and K. P. C. Kuypers. 2020. Reported effects of psychedelic use on those with low well-being given various emotional states and social contexts. Drug Science, Policy and Law 6:2050324519900068. doi:10.1177/2050324519900068.
   Google Scholar
• Millière, R., R. L. Carhart-Harris, L. Roseman, F.-M. Trautwein, and A. Berkovich-Ohana. 2018. Psychedelics, Meditation, and Self-Consciousness. Frontiers in Psychology 9:1475. doi:10.3389/fpsyg.2018.01475.
   PubMed Web of Science ®Google Scholar
• Montero-Marin, J., M. Puebla-Guedea, P. Herrera-Mercadal, A. Cebolla, J. Soler, M. Demarzo, C. Vazquez, F. Rodríguez-Bornaetxea, and J. García-Campayo. 2016. Psychological effects of a 1-month meditation retreat on experienced meditators: the role of non-attachment. Frontiers in Psychology 7 (1935). doi: 10.3389/fpsyg.2016.01935.
   Web of Science ®Google Scholar
• Móró, L., K. Simon, I. Bárd, and J. Rácz. 2011. Voice of the psychonauts: Coping, life purpose, and spirituality in psychedelic drug users. Journal of Psychoactive Drugs 43 (3):188–98. doi:10.1080/02791072.2011.605661.
   PubMed Web of Science ®Google Scholar
• Nichols, D. E. 2016. Psychedelics. Pharmacological Reviews 68 (2):264–355. doi:10.1124/pr.115.011478.
   PubMed Web of Science ®Google Scholar
• Parsons, C. E., C. Crane, L. J. Parsons, L. O. Fjorback, and W. Kuyken. 2017. Home practice in mindfulness-based cognitive therapy and mindfulness-based stress reduction: A systematic review and meta-analysis of participants’ mindfulness practice and its association with outcomes. Behaviour Research and Therapy 95:29–41. doi:10.1016/j.brat.2017.05.004.
   PubMed Web of Science ®Google Scholar
• Qualtrics, I. 2013. Qualtrics. Provo, UT, USA.
   Google Scholar
• Raglan, G. B. 2014. Decision making, mindfulness and mood: How mindfulness techniques can reduce the impact of biases and heuristics through improved decision making and positive affect. Journal of Depression and Anxiety 04 (1). doi: 10.4172/2167-1044.1000168.
   Google Scholar
• Roberts, C. A., I. Osborne-Miller, J. Cole, S. H. Gage, and P. Christiansen. 2020. Perceived harm, motivations for use and subjective experiences of recreational psychedelic “magic” mushroom use. Journal of Psychopharmacology 34 (9):999–1007. doi:10.1177/0269881120936508.
   PubMed Web of Science ®Google Scholar
• Schmidt, A. F., and C. Finan. 2018. Linear regression and the normality assumption. Journal of Clinical Epidemiology 98:146–51. doi:10.1016/j.jclinepi.2017.12.006.
   PubMed Web of Science ®Google Scholar
• Segal, Z. V., J. M. G. Williams, and J. D. Teasdale. 2001. Mindfulness-based cognitive therapy for depression, first edition: a new approach to preventing relapse. New York: Guilford Publications. https://play.google.com/store/books/details?id=VkvGwAEACAAJ.
   Google Scholar
• Shapiro, S. L., K. W. Brown, C. Thoresen, and T. G. Plante. 2011. The moderation of Mindfulness-based stress reduction effects by trait mindfulness: Results from a randomized controlled trial. Journal of Clinical Psychology 67 (3):267–77. doi:10.1002/jclp.20761.
   PubMed Web of Science ®Google Scholar
• Smigielski, L., M. Kometer, M. Scheidegger, R. Krähenmann, T. Huber, and F. X. Vollenweider. 2019a. Characterization and prediction of acute and sustained response to psychedelic psilocybin in a mindfulness group retreat. Scientific Reports 9 (1):14914. doi:10.1038/s41598-019-50612-3.
   PubMed Web of Science ®Google Scholar
• Smigielski, L., M. Scheidegger, M. Kometer, and F. X. Vollenweider. 2019b. Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects. NeuroImage 196:207–15. doi:10.1016/j.neuroimage.2019.04.009.
   PubMed Web of Science ®Google Scholar
• Spinelli, C., M. Wisener, and B. Khoury. 2019. Mindfulness training for healthcare professionals and trainees: A meta-analysis of randomized controlled trials. Journal of Psychosomatic Research 120:29–38. doi:10.1016/j.jpsychores.2019.03.003.
   PubMed Web of Science ®Google Scholar
• Steger, M. F., P. Frazier, S. Oishi, and M. Kaler. 2006. The meaning in life questionnaire: Assessing the presence of and search for meaning in life. Journal of Counseling Psychology 53 (1):80–93. doi:10.1037/0022-0167.53.1.80.
   Web of Science ®Google Scholar
• Vago, D. R., and D. A. Silbersweig. 2012. Self-awareness, self-regulation, and self-transcendence (S-ART): A framework for understanding the neurobiological mechanisms of mindfulness. Frontiers in Human Neuroscience 6:296. doi:10.3389/fnhum.2012.00296.
   PubMed Web of Science ®Google Scholar
• Van Lente, E., and M. J. Hogan. 2020. Understanding the nature of oneness experience in meditators using collective intelligence methods. Frontiers in Psychology 11:2092. doi:10.3389/fpsyg.2020.02092.
   PubMed Web of Science ®Google Scholar
• Verhaeghen, P. 2020. The examined life is wise living: the relationship between mindfulness, wisdom, and the moral foundations. Journal of Adult Development 27 (4):305–22. doi:10.1007/s10804-019-09343-y.
   Web of Science ®Google Scholar
• Watson, D., L. A. Clark, and A. Tellegen. 1988. Development and validation of brief measures of positive and negative affect: The PANAS scales. Journal of Personality and Social Psychology 54 (6):1063–70. doi:10.1037//0022-3514.54.6.1063.
   PubMed Web of Science ®Google Scholar
• White, H. 1980. A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity. Econometrica 48 (4):817. doi:10.2307/1912934.
   Web of Science ®Google Scholar
• Winstock, A. R. (2019). Global Drug Survey 2019. Global Drug Survey. Accessed December 2019. https://www.globaldrugsurvey.com/gds-2019/
   Google Scholar
• Yockey, R. A., R. A. Vidourek, and K. A. King. 2020. Trends in LSD use among US adults: 2015–2018. Drug and Alcohol Dependence 212:108071. doi:10.1016/j.drugalcdep.2020.108071.
   PubMed Web of Science ®Google Scholar